Michael Heckman

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke
    M G Heckman
    Biostatistics Unit, Mayo Clinic, Jacksonville, FL 32224, USA
    Eur J Neurol 20:300-8. 2013
  2. doi request reprint Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer
    Michael G Heckman
    Biostatistics Unit, Mayo Clinic Florida, Jacksonville, Florida 32224, USA
    Prostate 72:1757-66. 2012
  3. pmc Evaluation of the role of SNCA variants in survival without neurological disease
    Michael G Heckman
    Biostatistics Unit, Mayo Clinic, Jacksonville, Florida, United States of America
    PLoS ONE 7:e42877. 2012
  4. pmc In vivo silencing of alpha-synuclein using naked siRNA
    Jada Lewis
    Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Mol Neurodegener 3:19. 2008

Collaborators

Detail Information

Publications4

  1. pmc Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke
    M G Heckman
    Biostatistics Unit, Mayo Clinic, Jacksonville, FL 32224, USA
    Eur J Neurol 20:300-8. 2013
    ..This study evaluated whether genetic risk factors for CAD and MI also affect susceptibility to ischaemic stroke in Caucasians and African Americans...
  2. doi request reprint Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer
    Michael G Heckman
    Biostatistics Unit, Mayo Clinic Florida, Jacksonville, Florida 32224, USA
    Prostate 72:1757-66. 2012
    ..Herein, we provide the first evaluation of the ability of staining levels of the tumor based biomarkers MDM2, p16, and p53 to aid in prediction of biochemical recurrence (BCR) among men undergoing SRT for recurrent prostate cancer...
  3. pmc Evaluation of the role of SNCA variants in survival without neurological disease
    Michael G Heckman
    Biostatistics Unit, Mayo Clinic, Jacksonville, Florida, United States of America
    PLoS ONE 7:e42877. 2012
    ..This exploratory study examined whether SNCA variants may also promote successful aging as defined by survival without neurological disease...
  4. pmc In vivo silencing of alpha-synuclein using naked siRNA
    Jada Lewis
    Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Mol Neurodegener 3:19. 2008
    ..Genetic variability in SNCA contributes to risk of idiopathic Parkinson's disease (PD), possibly as a result of overexpression. SNCA downregulation is therefore a valid therapeutic target for PD...